PURPOSE: Tissue engineered skin substitutes are a promising tool to cover large skin defects, but little is known about reinnervation of transplants. In this experimental study, we analyzed the ingrowth of host peripheral nerve fibers into human tissue engineered dermo-epidermal skin substitutes in a rat model. Using varying cell types in the epidermal compartment, we wanted to assess the influence of epidermal cell types on reinnervation of the substitute. METHODS: We isolated keratinocytes, melanocytes, fibroblasts, and eccrine sweat gland cells from human skin biopsies. After expansion, epidermal cells were seeded on human dermal fibroblast-containing collagen type I hydrogels as follows: (1) keratinocytes only, (2) keratinocytes with melanocytes, (3) sweat gland cells. These substitutes were transplanted into full-thickness skin wounds on the back of immuno-incompetent rats and were analyzed after 3 and 8 weeks. Histological sections were examined with regard to myelinated and unmyelinated nerve fiber ingrowth using markers such as PGP9.5, NF-200, and NF-145. RESULTS: After 3 weeks, the skin substitutes of all three epidermal cell variants showed no neuronal ingrowth from the host into the transplant. After 8 weeks, we could detect an innervation of all three types of skin substitutes. However, the nerve fibers were restricted to the dermal compartment and we could not find any unmyelinated fibers in the epidermis. Furthermore, there was no distinct difference between the constructs resulting from the different cell types used to generate an epidermis. CONCLUSION: Our human tissue engineered dermo-epidermal skin substitutes demonstrate a host-derived innervation of the dermal compartment as early as 8 weeks after transplantation. Thus, our substitutes apparently have the capacity to attract nerve fibers from adjacent host tissues, which also grow into grafts and thereby potentially restore skin sensitivity.
PURPOSE: Tissue engineered skin substitutes are a promising tool to cover large skin defects, but little is known about reinnervation of transplants. In this experimental study, we analyzed the ingrowth of host peripheral nerve fibers into human tissue engineered dermo-epidermal skin substitutes in a rat model. Using varying cell types in the epidermal compartment, we wanted to assess the influence of epidermal cell types on reinnervation of the substitute. METHODS: We isolated keratinocytes, melanocytes, fibroblasts, and eccrine sweat gland cells from human skin biopsies. After expansion, epidermal cells were seeded on human dermal fibroblast-containing collagen type I hydrogels as follows: (1) keratinocytes only, (2) keratinocytes with melanocytes, (3) sweat gland cells. These substitutes were transplanted into full-thickness skin wounds on the back of immuno-incompetent rats and were analyzed after 3 and 8 weeks. Histological sections were examined with regard to myelinated and unmyelinated nerve fiber ingrowth using markers such as PGP9.5, NF-200, and NF-145. RESULTS: After 3 weeks, the skin substitutes of all three epidermal cell variants showed no neuronal ingrowth from the host into the transplant. After 8 weeks, we could detect an innervation of all three types of skin substitutes. However, the nerve fibers were restricted to the dermal compartment and we could not find any unmyelinated fibers in the epidermis. Furthermore, there was no distinct difference between the constructs resulting from the different cell types used to generate an epidermis. CONCLUSION: Our human tissue engineered dermo-epidermal skin substitutes demonstrate a host-derived innervation of the dermal compartment as early as 8 weeks after transplantation. Thus, our substitutes apparently have the capacity to attract nerve fibers from adjacent host tissues, which also grow into grafts and thereby potentially restore skin sensitivity.
Authors: James R Anderson; John S Zorbas; Jacqueline K Phillips; Joanne L Harrison; Linda F Dawson; Sarah E Bolt; Suzanne M Rea; Jennifer E Klatte; Ralf Paus; Bin Zhu; Natalie L Giles; Peter D Drummond; Fiona M Wood; Mark W Fear Journal: J Invest Dermatol Date: 2010-03-25 Impact factor: 8.551
Authors: Irene Montaño; Clemens Schiestl; Jörg Schneider; Luca Pontiggia; Joachim Luginbühl; Thomas Biedermann; Sophie Böttcher-Haberzeth; Erik Braziulis; Martin Meuli; Ernst Reichmann Journal: Tissue Eng Part A Date: 2010-01 Impact factor: 3.845
Authors: James R Anderson; Mark W Fear; Jacqueline K Phillips; Linda F Dawson; Hilary Wallace; Fiona M Wood; Suzanne M Rea Journal: Burns Date: 2011-05-04 Impact factor: 2.744
Authors: Sophie Böttcher-Haberzeth; Thomas Biedermann; Clemens Schiestl; Fabienne Hartmann-Fritsch; Jörg Schneider; Ernst Reichmann; Martin Meuli Journal: Pediatr Surg Int Date: 2012-02 Impact factor: 1.827
Authors: Sophie Böttcher-Haberzeth; Thomas Biedermann; Luca Pontiggia; Erik Braziulis; Clemens Schiestl; Bart Hendriks; Ossia M Eichhoff; Daniel S Widmer; Claudia Meuli-Simmen; Martin Meuli; Ernst Reichmann Journal: J Invest Dermatol Date: 2012-09-13 Impact factor: 8.551
Authors: Thomas Biedermann; Luca Pontiggia; Sophie Böttcher-Haberzeth; Sasha Tharakan; Erik Braziulis; Clemens Schiestl; Martin Meuli; Ernst Reichmann Journal: J Invest Dermatol Date: 2010-04-08 Impact factor: 8.551
Authors: R Scott Ward; Robert P Tuckett; Kathleen B English; Olle Johansson; Jeffrey R Saffle Journal: J Surg Res Date: 2004-05-15 Impact factor: 2.192
Authors: Luca Pontiggia; Thomas Biedermann; Martin Meuli; Daniel Widmer; Sophie Böttcher-Haberzeth; Clemens Schiestl; Jörg Schneider; Erik Braziulis; Irene Montaño; Claudia Meuli-Simmen; Ernst Reichmann Journal: J Invest Dermatol Date: 2008-08-21 Impact factor: 8.551
Authors: Sophie Böttcher-Haberzeth; Thomas Biedermann; Agnieszka S Klar; Luca Pontiggia; Jürgen Rac; David Nadal; Clemens Schiestl; Ernst Reichmann; Martin Meuli Journal: Pediatr Surg Int Date: 2014-02 Impact factor: 1.827
Authors: Agnes S Klar; Sinan Güven; Jakub Zimoch; Natalia A Zapiórkowska; Thomas Biedermann; Sophie Böttcher-Haberzeth; Claudia Meuli-Simmen; Ivan Martin; Arnaud Scherberich; Ernst Reichmann; Martin Meuli Journal: Pediatr Surg Int Date: 2015-11-30 Impact factor: 1.827
Authors: Thomas Biedermann; Agnieszka S Klar; Sophie Böttcher-Haberzeth; Teresa Michalczyk; Clemens Schiestl; Ernst Reichmann; Martin Meuli Journal: Pediatr Surg Int Date: 2014-10-18 Impact factor: 1.827
Authors: Thomas Biedermann; Agnieszka S Klar; Sophie Böttcher-Haberzeth; Clemens Schiestl; Ernst Reichmann; Martin Meuli Journal: Pediatr Surg Int Date: 2014-02 Impact factor: 1.827
Authors: Agnieszka S Klar; Sophie Böttcher-Haberzeth; Thomas Biedermann; Clemens Schiestl; Ernst Reichmann; Martin Meuli Journal: Pediatr Surg Int Date: 2014-02 Impact factor: 1.827